Walgreens Boots Alliance Reports Fiscal 2023 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CVS Health (CVS) Trades Lower in Sympathy Following Results from Walgreens (WBA)
June 27, 2023 7:11 AM EDTCVS Health (NYSE: CVS) Trades Lower in Sympathy Following Results from Walgreens (NASDAQ: WBA)
Walgreens revises full-year adjusted EPS guidance to $4.00 to $4.05 from $4.45 to $4.65, to reflect consumer and category conditions, lower COVID-19 contribution, and a more cautious macroeconomic forward viewWBA -7%CVS -2%
Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Cuts FY Guidance
June 27, 2023 7:01 AM EDT(Updated - June 27, 2023 7:03 AM EDT)
Walgreens Boots Alliance (NASDAQ: WBA) reported Q3 EPS of $1.00, $0.08 worse than the analyst estimate of $1.08. Revenue for the quarter came in at $35.4 billion versus the consensus estimate of $34.24 billion.
GUIDANCE:
Walgreens Boots Alliance sees... More
